Rising government funding for clinical trials, increased application of software solutions in clinical trials and clinical research, the growing customer base for e-Clinical solutions, are key factors contributing to the high CAGR of eClinical Solutions during the forecast period.
Market Size – USD 4267.6 Million in 2018, Market Growth - CAGR of 13.9%, Market Trends –Increasing clinical trials and application of software solutions in clinical research.
According to the current analysis of Reports and Data, the global eClinical Solutions market was valued at USD 4,267.6 Million in 2018 and is expected to reach USD 12,329.2 Million by the year 2026, at a CAGR of 13.9% from 2019-2026.
Clinical trials are the most time-consuming phase of drug development. The increasing demand for clinical trials by pharmaceutical giants and biotech companies propels the eClinical Solutions market growth. eClinical Solutions provide administrations to an enormous client base at a low working expense. Additionally, they help with tracking of information from different geographic areas, arranging, and execution of this information and drive the procedure of clinical advancement. E-clinical solutions are advantageous to reduce the time spent on assembling and analyzing data in clinical trials
Rise in appropriation of software solutions in eClinical research in trials offer various potential in clinical development processes. It can help in lowering the cost and reducing the time between development phase by identification of failing compounds. Moreover, it also offers data standardization and fast retrieval of data, which is beneficial in making quick decisions at every stage of development.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1847
The report provides a complete analysis of the global eClinical Solutions market with important details about the key market players from insightful primary and secondary research data. The report also aims to benefit the user by providing constructive data to gain insight into the market growth, size, and investment approaches.
The key companies profiled in the market are:
Oracle Corporation, Medidata Solutions, PAREXEL International Corporation, BioClinica, CRF Health, DATATRAK International, ERT, eClinical Solutions.
Further key findings from the report suggest
- CDMS led the product segment in 2018 with 27% eClinical solutions market share owing to various benefits provided by the product such as end-to-end management of various databases, clinical trial activities and real-time status tracking, which in total improves the general effectiveness of clinical trials.
- eClinical Solution system, especially, the Cloud-based delivery system is expected to grow at the CAGR of 14.8% owing to ease of integration and rapid deployment.
- Increasing clinical research in developing countries such as India, Bangladesh is expected to support the growth of eClinical Solutions market during the forecast years.
- Increasing Research and development by pharmaceuticals and biotechnology companies, resulting in the launch of new products are some of the factors that support the eClinical solutions market growth during forecast years. For Instance, in 2018, Oracle a new holistic, unified cloud-based eClinical solution, Clinical One Platform with the intention of launching new drugs in the market with a focus on quality and safety.
For the purpose of this report, Reports and Data has segmented the eClinical solutions market on the basis of product, development phase, mode of delivery, end use, and region:
Product (Revenue, USD Million; 2016–2026)
- Electronic Clinical Outcome Assessment (ECOA)
- Electronic Data Capture (EDC) & Clinical Data Management Systems (CDMS)
- Clinical Analytics Platforms
- Clinical Data Integration Platforms
- Safety Solutions
- Clinical Trial Management Systems (CTMS)
- Randomization and Trial Supply Management (RTSM)
- Electronic Trial Master File (eTMF)
Development Phase (Revenue, USD Million; 2016–2026)
- Phase I
- Phase II
- Phase III
- Phase IV
Mode of Delivery (Revenue, USD Million; 2016–2026)
- Web Hosted
- Licensed Enterprise
- Cloud-based
End Use (Revenue, USD Million; 2016–2026)
- Hospitals
- Contract Research Organizations (CROs)
- Academic Institutes
- Pharmaceuticals & Biotech Organizations
- Medical Device Manufacturers
Browse Complete Report “eClinical Solutions Market” @ https://www.reportsanddata.com/report-detail/eclinical-solutions-market
The report further segments the market on the basis of key regions of the world and offers an assessment of the production and manufacturing capacity, import and export, production and consumption patterns, supply and demand ratio, and the presence of key players in each region. The eClinical Solutions market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
In-depth regional analysis covers:
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- A.E.
- Rest of MEA
The report includes primary and subjective research with a comprehensive study examined and validated by industry professionals and experts. The report further provides insights into the opportunities and threats that the industry may witness in the upcoming years, throughout the forecast period. The report also provides an insight into the growth in revenue along with CAGR throughout the forecast period. It also provides insights into lucrative opportunities to enable the businesses to capitalize on the emerging trends of the market.
Request customization of the report @ https://www.reportsanddata.com/request-customization-form/1847
Highlights of the TOC:
- Report Overview
1.1 Research Scope
1.2 Key eClinical Solutions market segments
1.3 Major players
1.4 Market analysis by product
1.5 Market analysis by application
1.6 Report timeline
- Global Growth Trends
2.1 Global eClinical Solutions market size
2.2 Latest eClinical Solutions market trends
2.3 Key growth trends
- Competitive Landscape
3.1 Global eClinical Solutions market key players
3.2 Global eClinical Solutions size by manufacturers
3.3 Products of major players
3.4 Entry barriers in the eClinical Solutions market
3.5 Mergers, acquisitions, joint ventures, and strategic alliances
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Thank you for reading our report. For additional information on customization of the report, connect with us and we will make sure you get a report tailored to meet your needs.
eClinical Solutions Market, eClinical Solutions Market size, eClinical Solutions Market share, eClinical Solutions Market trends, eClinical Solutions Market forecast, eClinical Solutions Market analysis, eClinical Solutions Market scope, eClinical Solutions Market manufacturer, eClinical Solutions Market vendors, eClinical Solutions Market players, eClinical Solutions Market top player, eClinical Solutions Market key player, eClinical Solutions Market prominent player, eClinical Solutions Market major manufacturers, eClinical Solutions Market report .
Growing global incidence of substance abuse, increasing cases of prescription diversion, and stringent laws mandating drug screening tests are key factors driving market growth Market Size – USD 1.25 Billion in 2020, Market Growth – at a CAGR of 6.6%, Market Trends – Increasing adoption of urine drug testing at workplaces The global specimen validity testing market size is expected to reach USD 2.10 Billion by 2028 at a CAGR of 6.6%, according to the latest report by Reports and Data.
Clinicians generally order SVT to make informed therapeutic decisions about medical conditions of their patients, which also includes therapeutic overuse and illicit drug abuse.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4098Some Key Highlights From the Report:Reagents, calibrators, and controls segment is expected to account for largest revenue share among the products segment.
Growth can be attributed to increasing demand and repeated purchase of reagents due to rising number of specimens being tested in drug screening laboratories.Laboratory testing segment is expected to register robust revenue CAGR over the forecast period owing to increasing drug testing in established healthcare facilities, rising cases of drug abuse, and implementation of standardized specimen validity testing protocols in laboratories.Workplace segment is expected to register significant revenue growth over the forecast period owing to rising incidence of drug abuse at workplaces and increasing number of offices and organizations mandating workplace drug screening.North America is expected to account for largest revenue share between 2021 and 2028, attributable to growing use of illicit drugs, increasing incidence of prescription diversion, and presence of stringent laws mandating drug screening in countries in the region.
The key companies profiled in the market are: Thermo Fisher Scientific, Inc., Sciteck, American Bio Medica Corporation, Alere, Express Diagnostics, Premier Biotech, LabCorp., Quest Diagnostics, Alere Toxicology, ACM Global Laboratories, Clinical Reference Laboratory (CRL), SureHire, and CannAmm.For the purpose of this report, Reports and Data has segmented the global specimen validity testing market based on product & services, type, end-use, and region: Product & Services Outlook (Revenue, USD Billion; 2018-2028)ProductsReagents, Calibrators, & ControlsAssay KitsDisposableServicesType Outlook (Revenue, USD Billion; 2018-2028)Laboratory TestingRapid/POC TestingEnd-use Outlook (Revenue, USD Billion; 2018-2028) WorkplacesDrug Screening LaboratoriesLaw Enforcement AgenciesPain Management CentresDrug Rehabilitation CentresOthers Browse Complete Report “Specimen Validity Testing Market” @ https://www.reportsanddata.com/report-detail/specimen-validity-testing-marketThe report further segments the market on the basis of key regions of the world and offers an assessment of the production and manufacturing capacity, import and export, production and consumption patterns, supply and demand ratio, and the presence of key players in each region.
In-depth regional analysis covers: North AmericaU.S.CanadaMexicoEuropeGermanyU.K.FranceBENELUXRest of EuropeAsia PacificChinaJapanSouth KoreaRest of APACLatin AmericaBrazilRest of LATAMMiddle East & AfricaSaudi ArabiaA.E.Rest of MEAThe report includes primary and subjective research with a comprehensive study examined and validated by industry professionals and experts.
The Global Bovine Blood Plasma Derivatives Market research report published by Reports and Data offers a comprehensive evaluation of the Bovine Blood Plasma Derivatives market on the global scale and sheds light on the growth opportunities, prospects, and enables the readers to formulate strategic plans.
The report offers an in-depth analysis of the value chain, upstream and downstream factors, sales network and distribution channels, growth trends, driving and restraining factors, developments, production and consumption pattern, end-users, and regional segmentation.
The report also offers relevant and useful information to help the new entrants and established companies strengthen their market position.Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3508The report provides extensive coverage of the supply chain, key players of the industry, consumer base, company profiles, production and consumption rate, primary applications, and other relevant data.
It provides an in-depth assessment of the key companies operating in the market along with their company profiles, business overview, production and manufacturing capacity, product portfolio, financial standing, global position, and business expansion plans.
The report also provides insights into new entrants and their strategic alliances to gain a robust footing in the market.Key Manufacturers in the Global Bovine Blood Plasma Derivatives Market:LAMPIRE Biological Laboratories, Inc., Sigma-Aldrich Co. (Merck KGaA), Rocky Mountain Biologicals Inc., Proliant Inc., Bovogen Biologicals Pty Ltd., Thermo Fisher Scientific, Inc., Kraeber & Co GmbH, Auckland BioSciences Ltd., and Lake Immunogenics, Inc.Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/3508The report also provides an extensive regional segmentation to offer the readers key insights into the spread of the market over key geographical regions.
It covers production and consumption patterns, import/export, supply and demand, consumer demand and behavior, key trends, and presence of key players in each region.
High demand for metabolomics from various research institutes and pharmaceutical & biotechnology companies is a key factor driving market revenue growthThe global metabolomics market size is expected to reach USD 5.10 Billion in 2028 and register a CAGR of 13.2% over the forecast period, according to the latest report by Reports and Data.
In addition, in developed countries, presence of state-of-the-art healthcare infrastructure for precise diagnosis and treatment of various disorders is expected to drive market growth during the forecast period.Demand for metabolomics is increasing because of its ability to work as a drug discovering tool.
Metabolomics is utilized for discovering different types of drugs as it can improve testing and discovery of novel drugs.However, lack of awareness about metabolomics in underdeveloped countries, complexity of data generated during research activities, lack of advanced healthcare facilities in emerging countries, and high cost of novel tools and equipment can hamper market growth over the forecast period.Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4641Some Key Highlights From the Report:By application, biomarker discovery segment accounted for the largest revenue share in 2020.
Rising awareness among people, presence of a well-developed healthcare infrastructure for supporting R activities, and technological advancements are anticipated to propel growth of this region.
Apart from that, increasing geriatric population and rising number of research & development activities in the field of metabolomics would also drive revenue growth of the market in this region.Regional Outlook:North America is the largest market for healthcare, followed by Asia-Pacific, Western Europe and then the other regions.
As the market in developed countries is nearly saturated, market players have shifted their focus toward the developing regions, especially the emerging economies of Asia Pacific.Get a Discount @ https://www.reportsanddata.com/discount-enquiry-form/4641Competitive Outlook:The prominent factors favoring market growth include increasing launches and initiatives by the market players to provide rapid treatment for addressing the diseases of the patients in the healthcare industry.
Rising number of cancer cases, growing incidence of infectious diseases, strong government funding for medical science and the increasing application of patient-specific treatments are key factors contributing to high CAGR of Molecular Diagnostics during the forecast period.Market Size – USD 7.28 Billion in 2018, Market Growth - CAGR of 8.2%, Market Trends – impressive growth in colorectal cancer molecular diagnostics marketThe report on the global Molecular Diagnostics Market published by Reports and Data provides an in-depth assessment of the Molecular Diagnostics market including recent technological and product advancements, market drivers, challenges, current and emerging trends, opportunities, threats, risks, strategic developments, and other key features.
The report comprises 100+ pages and covers comprehensive assessment of market size, market share, revenue contribution, revenue share, growth rate, industrial chain analysis, regional analysis, and top companies.
It also provides strategic recommendations to formulate investment strategies and provides insights for new entrants.Get a sample of the report @ https://reportsanddata.com/sample-enquiry-form/945The report provides an in-depth analysis of the key developments and innovations of the market such as research and development advancements, product launches, mergers & acquisitions, joint ventures, partnerships, government deals, and collaborations.
The report offers a comprehensive assessment of key players in the market along with their global position, financial standing, business expansion plans, production and manufacturing capacity, and strategic alliances.Key players in the market include Abbott, Roche Diagnostics, QIAGEN, Danaher, Hologic, Becton, Siemens Healthcare GmbH, Bio-Rad Laboratories, Dickinson and Co., CepheidFor a better understanding of the global Molecular Diagnostics market dynamics, a regional analysis of the market across key geographical areas is offered in the report.
The market is spread across key geographical regions such as North America, Europe, Latin America, Asia Pacific, and Middle East & Africa.
Each region is analysed on the basis of the market scenario in the major countries of the regions to provide a deeper understanding of the market.
